Literature DB >> 3545439

Phosphaturic mesenchymal tumors. A polymorphous group causing osteomalacia or rickets.

N Weidner, D Santa Cruz.   

Abstract

Reported are the pathologic features of 17 mesenchymal tumors documented as causing osteomalacia or rickets. Although these tumors were histologically polymorphous, they were classifiable into four morphological groups. In the first group there were ten unique tumors showing mixed connective tissue features and containing variably prominent vascular and/or osteoclast-like giant-cell components. Tumors of this group also displayed focal microcystic changes, osseous metaplasia, and/or poorly developed cartilaginous areas. The cartilaginous areas sometimes showed considerable dystrophic calcification. With one exception, all tumors of this group occurred in soft tissue and demonstrated benign clinical behavior. The single malignant tumor originated in bone, recurred locally, and metastasized to lung. The tumors comprising the remaining three groups (six tumors) occurred in bone, demonstrated benign clinical behavior, and were grouped according to their close resemblance to tumors known to occur in bone, that is osteoblastoma-like (four tumors), nonossifying fibroma-like (two tumors), and ossifying fibroma-like (one tumor).

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3545439     DOI: 10.1002/1097-0142(19870415)59:8<1442::aid-cncr2820590810>3.0.co;2-q

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  70 in total

Review 1.  Hereditary disorders of renal phosphate wasting.

Authors:  Amir S Alizadeh Naderi; Robert F Reilly
Journal:  Nat Rev Nephrol       Date:  2010-10-05       Impact factor: 28.314

Review 2.  The expanding family of hypophosphatemic syndromes.

Authors:  Thomas O Carpenter
Journal:  J Bone Miner Metab       Date:  2011-12-14       Impact factor: 2.626

Review 3.  Miscellaneous non-inflammatory musculoskeletal conditions. Hyperphosphatemic familial tumoral calcinosis (FGF23, GALNT3 and αKlotho).

Authors:  Emily G Farrow; Erik A Imel; Kenneth E White
Journal:  Best Pract Res Clin Rheumatol       Date:  2011-10       Impact factor: 4.098

4.  Tumor-Induced Osteomalacia.

Authors:  Rajiv Kumar; Andrew L Folpe; Brian P Mullan
Journal:  Transl Endocrinol Metab       Date:  2015

5.  Phosphaturic mesenchymal tumor of the tibia with oncogenic osteomalacia in a teenager.

Authors:  Shannon G Farmakis; Marilyn J Siegel
Journal:  Pediatr Radiol       Date:  2015-02-27

Review 6.  Lymphatic vessels are present in phosphaturic mesenchymal tumours.

Authors:  K Williams; A Flanagan; A Folpe; R Thakker; N A Athanasou
Journal:  Virchows Arch       Date:  2007-08-03       Impact factor: 4.064

7.  Diffuse pain, hypophosphatemia, and a subcutaneous nodule.

Authors:  Christine A Dewitt; Michael T Collins; Edward W Cowen
Journal:  J Am Acad Dermatol       Date:  2007-09       Impact factor: 11.527

8.  Successful Localization Using 68Ga-DOTATOC PET/CT of a Phosphaturic Mesenchymal Tumor Causing Osteomalacia in a Patient with Concurrent Follicular Lymphoma.

Authors:  Sejin Ha; Sujin Park; Hyunji Kim; Heounjeong Go; Seung Hun Lee; Ji Yoon Choi; Jung Yong Hong; Jin-Sook Ryu
Journal:  Nucl Med Mol Imaging       Date:  2018-09-12

9.  Following the forgotten phosphorus.

Authors:  Lekshmi T Nair; Leslie Dodd; Thomas J Weber
Journal:  Am J Med       Date:  2009-12       Impact factor: 4.965

Review 10.  Phosphaturic Mesenchymal Tumor: 2 New Oral Cases and Review of 53 Cases in the Head and Neck.

Authors:  Hiba Qari; Aya Hamao-Sakamoto; Clay Fuselier; Yi-Shing Lisa Cheng; Harvey Kessler; John Wright
Journal:  Head Neck Pathol       Date:  2015-11-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.